Detalhe da pesquisa
1.
Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.
Int J Mol Sci
; 24(14)2023 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511593
2.
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides.
J Hepatol
; 64(4): 781-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26658683
3.
Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.
J Hepatol
; 56(6): 1269-75, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22314422
4.
Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus-Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses.
Clin Pharmacol Drug Dev
; 11(10): 1191-1202, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971951
5.
In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Gastroenterology
; 136(1): 168-176.e2, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18996386
6.
The Prevalence of Antibodies against Sandfly Fever Viruses and West Nile Virus in Cyprus.
J Arthropod Borne Dis
; 13(1): 116-125, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346541
7.
The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication.
Antiviral Res
; 92(2): 271-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21871497
8.
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.
J Hepatol
; 48(5): 747-55, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18331765